Maze Therapeutics (MAZE) Total Current Liabilities (2024 - 2026)
Maze Therapeutics (MAZE) posted Total Current Liabilities of $21.2 million for Q1 2026, down 5.85% sequentially from $22.6 million in Q4 2025, and up 14.07% YoY from $18.6 million in Q1 2025.
Maze Therapeutics (MAZE) Total Current Liabilities (2024 - 2026) Analysis & Trends
Maze Therapeutics has reported Total Current Liabilities for 3 years, with the latest figure at $21.2 million in Q1 2026.
- Quarterly Total Current Liabilities rose 14.07% year-over-year to $21.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $21.2 million (up 14.07% YoY) and the FY2025 annual result came in at $22.6 million, up 9.11% from the prior year.
- Total Current Liabilities eased to $21.2 million in Q1 2026 per MAZE's latest filing, from $22.6 million in the prior quarter.
- Over five years, Total Current Liabilities peaked at $22.6 million in Q4 2025 and troughed at $18.6 million in Q1 2025.
- A 3-year average of $20.8 million and a median of $21.0 million in 2024 frame the typical range for Total Current Liabilities.
- The sharpest annual moves came in 2025 and 2026: Total Current Liabilities rose 9.11% in 2025, then climbed 14.07% in 2026.
- Over 3 years, Total Current Liabilities stood at $20.7 million in 2024, then rose by 9.11% to $22.6 million in 2025, then declined by 5.85% to $21.2 million in 2026.
- According to Business Quant data, Total Current Liabilities over the past three periods registered $21.2 million, $22.6 million, and $22.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 3.94 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 5.53 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.58 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 354.06 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 2.12 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 4.22 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 630.93 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.51 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 438.74 Mn |
| 10 | Maze Therapeutics | 1.51 Bn | 1.51 Bn | - | 22.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 22.96 Mn |
| Mar 31, 2026 | 21.24 Mn |
| Dec 31, 2025 | 22.56 Mn |
| Sep 30, 2025 | 22.11 Mn |
| Jun 30, 2025 | 19.90 Mn |
| Mar 31, 2025 | 18.62 Mn |
| Dec 31, 2024 | 20.67 Mn |